SIGNATUREFD, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$40,221
+5.2%
4490.0%0.00%0.0%
Q2 2023$38,228
+2.9%
4490.0%0.00%0.0%
Q1 2023$37,155
+51.4%
449
+43.9%
0.00%0.0%
Q4 2022$24,539
+6.7%
3120.0%0.00%0.0%
Q3 2022$23,000
+35.3%
312
+17.3%
0.00%0.0%
Q2 2022$17,000
+183.3%
266
+186.0%
0.00%
Q1 2022$6,000
+100.0%
93
+52.5%
0.00%
Q4 2021$3,000
-85.7%
61
-79.3%
0.00%
-100.0%
Q3 2021$21,000
+320.0%
294
+286.8%
0.00%
Q2 2021$5,000
+150.0%
76
+347.1%
0.00%
Q1 2021$2,000
-33.3%
17
-34.6%
0.00%
Q4 2020$3,000
+200.0%
26
+116.7%
0.00%
Q3 2020$1,000
-50.0%
12
-36.8%
0.00%
Q2 2020$2,000
-93.5%
19
-93.9%
0.00%
-100.0%
Q1 2020$31,000
-13.9%
3120.0%0.00%0.0%
Q4 2019$36,000
-7.7%
3120.0%0.00%0.0%
Q3 2019$39,000
+2.6%
3120.0%0.00%0.0%
Q2 2019$38,000
+40.7%
3120.0%0.00%
+50.0%
Q1 2019$27,000
-15.6%
312
-2.2%
0.00%
-33.3%
Q4 2018$32,000
-13.5%
3190.0%0.00%
-25.0%
Q3 2018$37,000
+27.6%
3190.0%0.00%
+33.3%
Q2 2018$29,000
+26.1%
319
+2.2%
0.00%0.0%
Q1 2018$23,0003120.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders